COMPARATIVE EFFECTIVENESS OF DELAYED-RELEASE DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE ON RISK OF RELAPSE

被引：0
|
作者：
Nicholas, Jacqueline [1 ]
Boster, Aaron [1 ]
Wu, Ning [2 ]
Huang, Ming-Yi [2 ]
Riester, Katherine [2 ]
Jhaveri, Mehul [2 ]
Edwards, Michael [2 ]
Lee, Andrew [2 ]
机构：
[1] OhioHlth Multiple Sclerosis Ctr, Columbus, OH USA
[2] Biogen, Cambridge, MA USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.375
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada
    Su, Wenqing
    Kansal, Anuraag
    Vicente, Colin
    Deniz, Baris
    Sarda, Sujata
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (07) : 718 - 727
  • [32] Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States
    Mauskopf, Josephine
    Fay, Monica
    Iyer, Ravi
    Sarda, Sujata
    Livingston, Terrie
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (04) : 432 - 442
  • [33] COST-EFECTIVENESS OF DELAYED-RELEASE DIMETHYL FUMARATE COMPARED TO GLATIRAMER ACETATE AND FINGOLIMOD FOR THE TREATMENT OF RELAPSING-REMITING MULTIPLE SCLEROSIS
    Mauskopf, J. A.
    Fay, M.
    Iyer, R.
    Livingston, T.
    VALUE IN HEALTH, 2014, 17 (03) : A60 - A61
  • [34] Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and glatiramer acetate in multiple sclerosis patients
    Chan, A.
    Cutter, G.
    Fox, R.
    Zhang, A.
    Xiao, J.
    Lewin, J.
    Edwards, M.
    Marantz, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 401 - 401
  • [35] Real-world Effectiveness of Dimethyl Fumarate Versus Fingolimod on Cognitive Outcomes
    Hersh, Carrie
    Altincatal, Arman
    de Moor, Carl
    Williams, James R.
    Miller, Catherine
    Koulinska, Irene
    NEUROLOGY, 2021, 96 (15)
  • [36] Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis
    Kappos, L.
    Giovannoni, G.
    Gold, R.
    Phillips, J. T.
    Arnold, D. L.
    Hotermans, C.
    Zhang, A.
    Viglietta, V.
    Fox, R. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (04) : 664 - 671
  • [37] Management Strategies to Facilitate Optimal Outcomes for Patients Treated with Delayed-release Dimethyl Fumarate
    Lori Mayer
    Mary Kay Fink
    Carrie Sammarco
    Lisa Laing
    Drug Safety, 2018, 41 : 347 - 356
  • [38] Efficacy Of Delayed-release Dimethyl Fumarate In Patients ≥55 Years Enrolled In The RESPOND Study
    Repovic, P.
    Robertson, D.
    Cohan, S. L.
    Mao-Draayer, Y.
    Xiong, K.
    Borowski, J.
    Avila, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 31 - 32
  • [39] PREGNANCY OUTCOMES WITH DELAYED-RELEASE DIMETHYL FUMARATE: INTERIM RESULTS FROM AN INTERNATIONAL REGISTRY
    Everage, Nicholas J.
    Liu, Shifang
    Yun, Jang
    Prada, Claudia
    Hanna, Jerome
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E22 - E22
  • [40] Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study
    Arnold, Douglas L.
    Gold, Ralf
    Kappos, Ludwig
    Bar-Or, Amit
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Yang, Minhua
    Zhang, Ray
    Stephan, Monica
    Sheikh, Sarah I.
    Dawson, Katherine T.
    JOURNAL OF NEUROLOGY, 2014, 261 (09) : 1794 - 1802
12345